Albireo Pharma, Inc.
ALBO · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$40 | -$42 | -$11 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $4 | $4 | $4 | $3 |
| Change in WC | $1 | -$3 | -$7 | -$12 |
| Other Non-Cash | $4 | $3 | $10 | $3 |
| Operating Cash Flow | -$30 | -$36 | -$35 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $21 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $121 | $2 | $4 | $0 |
| Financing Cash Flow | $121 | $2 | $4 | $0 |
| Forex Effect | -$0 | -$0 | -$0 | -$1 |
| Net Chg. in Cash | $92 | -$36 | -$31 | -$15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $181 | $217 | $248 | $263 |
| End Cash | $272 | $181 | $217 | $248 |
| Free Cash Flow | -$30 | -$37 | -$36 | -$14 |